RPTX logo

Repare Therapeutics (RPTX)

Profile

Full Name

Repare Therapeutics Inc.

Ticker Symbol

RPTX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Canada

IPO

June 19, 2020

Indexes

Not included

Website

http://www.reparerx.com

Employees

129

Key Details

Price

$0.90(0.00%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$53.48M(+4.58% YoY)

Annual EPS

-$2.00(+10.31% YoY)

PE ratio

-

Next earnings date

May 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.90
RPTX price is $0.90

30-Day Relative Volume

1.60
RPTX 30-day relative volume is 1.60

Price Performance

Price Most recent change

0%
RPTX {parameterFullLabel} has remained unchanged on Apr 11, 2025

Price YTD change

-31.3%
RPTX price is down -31.3% since January 1st

Price 1-year change

-76.92%
RPTX price is down -76.92% year-on-year

Price 3-year change

-91.32%
RPTX price is down -91.32% over the past 3 years

Price Range

Price All-time high

$46.44
RPTX price is currently -98.06% below its historical high of $46.44

Price 3-year low

$0.89
RPTX price is currently +1.12% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$38.26M
RPTX market capitalization is $38.26 million

Market cap 3-year change

-91.19%
RPTX market capitalization is down -91.19% over the past 3 years

Market cap All-time high

$1.64B
RPTX market capitalization is currently -97.67% below its historical high of $1.64 billion

Market cap sector rank

34.92%
RPTX market capitalization is higher than 34.92% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.15%
RPTX shares outstanding is up +0.15% year-on-year

Shares Outstanding 3-Year Change

+1.51%
RPTX shares outstanding is up +1.51% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.70
RPTX beta is 0.70

200-day SMA

$2.46
RPTX price is currently -63.45% below its 200-day simple moving average

50-day SMA

$1.14
RPTX price is currently -21.05% below its 50-day simple moving average

RSI

29.62
RPTX 14-day relative strength index is 29.62

Volume

1.60
RPTX 30-day relative volume is 1.60

ATR

$0.07
RPTX average true range is $0.07

10-day Historical Volatility

55.36%
RPTX 10-day historical volatility is 55.36%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$53.48M
RPTX annual revenue is $53.48 million

Revenue Analysts estimate

$6.67M
RPTX annual revenue is currently +702.15% higher than the consensus analysts' forecast

Revenue 1-year change

+4.58%
RPTX annual revenue is up +4.58% year-on-year

Revenue Sector rank

47.48%
RPTX annual revenue is higher than 47.48% of companies in Healthcare sector

EPS

EPS

-$2.00
RPTX annual earnings per share is -$2.00

EPS Analysts estimate

-$2.11
RPTX annual earnings per share is currently -5.21% lower than the consensus analysts' forecast

EPS 1-year change

+10.31%
RPTX annual earnings per share is up +10.31% year-on-year

EPS Sector rank

38.73%
RPTX annual earnings per share is higher than 38.73% of companies in Healthcare sector

Profit

Gross profit

-
RPTX annual gross profit value is unknown

Gross margin

-
RPTX annual gross profit margin value is unknown

Operating profit

-$92.14M
RPTX annual operating income is -$92.14 million

Operating margin

-172.31%
RPTX annual operating profit margin is -172.31%

Net income

-$84.69M
RPTX annual net profit is -$84.69 million

Net margin

-158.37%
RPTX annual net profit margin is -158.37%

Expenses

Total expenses

$145.62M
RPTX annual total expenses is $145.62 million

Operating expenses

$145.62M
RPTX annual total operating expenses is $145.62 million

Cost of goods sold

-
RPTX annual cost of goods sold value is unknown

Selling, general & administrative expenses

$29.68M
RPTX annual SGA is $29.68 million

Depreciation and amortization

$1.92M
RPTX annual depreciation & amortization is $1.92 million

Interest expense

-
RPTX annual interest expense value is unknown

Income tax

$1.44M
RPTX annual income tax is $1.44 million

EBIT & EBITDA

EBIT

-$92.14M
RPTX annual earnings before interest & taxes is -$92.14 million

EBITDA

-$90.22M
RPTX annual EBITDA is -$90.22 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$176.51M
RPTX annual total assets is $176.51 million

Non current assets

$5.36M
RPTX annual long term assets is $5.36 million

Current assets

$171.15M
RPTX annual total current assets is $171.15 million

Cash and cash equivalents

$84.72M
RPTX annual cash & cash equivalents is $84.72 million

Accounts receivable

-
RPTX annual accounts receivable value is unknown

Inventory

-
RPTX annual inventory value is unknown

Liabilities

Total liabilities

$25.38M
RPTX annual total liabilities is $25.38 million

Long term liabilities

$88.00K
RPTX annual total long term liabilities is $88.00 thousand

Current liabilities

$25.29M
RPTX annual total current liabilities is $25.29 million

Accounts payable

$3.62M
RPTX annual accounts payable is $3.62 million

Debt

Total debt

$1.93M
RPTX annual total debt is $1.93 million

Total debt 1-year change

-43.31%
RPTX annual total debt is down -43.31% year-on-year

Long term debt

$88.00K
RPTX annual long term debt is $88.00 thousand

Short term debt

$1.84M
RPTX annual short term debt is $1.84 million

Equity & Capital

Shareholders equity

$151.13M
RPTX annual stockholders equity is $151.13 million

Book value

$151.13M
RPTX annual book value is $151.13 million

Retained earnings

-$417.80M
RPTX annual retained earnings is -$417.80 million

Working capital

$145.86M
RPTX annual working capital is $145.86 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$76.44M
RPTX annual cash flow from operations is -$76.44 million

Cash from operations 1-year change

+39.88%
RPTX annual cash flow from operations is up +39.88% year-on-year

Cash from investing

$49.47M
RPTX annual cash flow from investing activities is $49.47 million

Cash from investing 1-year change

-36.61%
RPTX annual cash flow from investing activities is down -36.61% year-on-year

Cash from financing

$542.00K
RPTX annual cash flow from financing activities is $542.00 thousand

Cash from financing 1-year change

-35.63%
RPTX annual cash flow from financing activities is down -35.63% year-on-year

CAPEX

CAPEX

-
RPTX annual capital expenditures value is unknown

CAPEX 1-year change

-
RPTX annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$76.44M
RPTX annual free cash flow is -$76.44 million

Free cash flow 1-year change

+40.78%
RPTX annual free cash flow is up +40.78% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
RPTX annual gross profit margin value is unknown

Operating margin

-172.31%
RPTX annual operating profit margin is -172.31%

Net margin

-158.37%
RPTX annual net profit margin is -158.37%

ROA & ROE

ROA

-39.35%
RPTX annual return on assets is -39.35%

ROE

-46.63%
RPTX annual return on equity is -46.63%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
RPTX price to earnings ratio value is unknown

PE ratio Sector rank

-
RPTX price to earnings ratio is unknown

PB Ratio

PB ratio

0.25
RPTX price to book ratio is 0.25

PB ratio Sector rank

21.79%
RPTX price to book ratio is higher than 21.79% of companies in Healthcare sector

PS Ratio

PS ratio

-
RPTX price to sales ratio value is unknown

PS ratio Sector rank

-
RPTX price to sales ratio is unknown

Enterprise value

Enterprise value

-$44.52M
RPTX enterprise value is -$44.52 million

Enterprise value Sector rank

1.9%
RPTX enterprise value is higher than 1.9% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.49
RPTX EV/EBITDA is 0.49

EV/EBITDA Sector rank

72.02%
RPTX EV/EBITDA is higher than 72.02% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

6.77
RPTX annual current ratio is 6.77

Quick ratio

-
RPTX annual quick ratio value is unknown

Leverage

Debt to equity

0.00
RPTX annual debt to equity ratio is 0.00

Interest coverage ratio

-
RPTX annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
RPTX piotroski f-score value is unknown

Altman Z-Score

-2.84
RPTX altman z-score is -2.84

Analyst ratings

Recent major analysts updates

Mar 7, 25 HC Wainwright & Co.
Buy
Dec 13, 24 Stifel
Buy
Dec 13, 24 LifeSci Capital
Market Perform
Nov 8, 24 HC Wainwright & Co.
Buy
Oct 24, 24 HC Wainwright & Co.
Buy
Sep 23, 24 HC Wainwright & Co.
Buy
Sep 4, 24 HC Wainwright & Co.
Buy
Jun 5, 24 HC Wainwright & Co.
Buy
May 30, 24 HC Wainwright & Co.
Buy
Mar 8, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

ITRM logo
Iterum Therapeutics (ITRM)
NVNO logo
enVVeno Medical (NVNO)
ANTX logo
AN2 Therapeutics (ANTX)
TELA logo
TELA Bio (TELA)
MRSN logo
Mersana Therapeutics (MRSN)
Rein Therapeutics (RNTX)
PRLD logo
Prelude Therapeutics Incorporated (PRLD)
Advanced Biomed (ADVB)
DYAI logo
Dyadic International (DYAI)
  • What is the ticker symbol for Repare Therapeutics?
  • Does Repare Therapeutics pay dividends?
  • What sector is Repare Therapeutics in?
  • What industry is Repare Therapeutics in?
  • What country is Repare Therapeutics based in?
  • When did Repare Therapeutics go public?
  • Is Repare Therapeutics in the S&P 500?
  • Is Repare Therapeutics in the NASDAQ 100?
  • Is Repare Therapeutics in the Dow Jones?
  • When was Repare Therapeutics's last earnings report?
  • When does Repare Therapeutics report earnings?
  • Should I buy Repare Therapeutics stock now?

What is the ticker symbol for Repare Therapeutics?

The ticker symbol for Repare Therapeutics is NASDAQ:RPTX

Does Repare Therapeutics pay dividends?

No, Repare Therapeutics does not pay dividends

What sector is Repare Therapeutics in?

Repare Therapeutics is in the Healthcare sector

What industry is Repare Therapeutics in?

Repare Therapeutics is in the Biotechnology industry

What country is Repare Therapeutics based in?

Repare Therapeutics is headquartered in Canada

When did Repare Therapeutics go public?

Repare Therapeutics's initial public offering (IPO) was on June 19, 2020

Is Repare Therapeutics in the S&P 500?

No, Repare Therapeutics is not included in the S&P 500 index

Is Repare Therapeutics in the NASDAQ 100?

No, Repare Therapeutics is not included in the NASDAQ 100 index

Is Repare Therapeutics in the Dow Jones?

No, Repare Therapeutics is not included in the Dow Jones index

When was Repare Therapeutics's last earnings report?

Repare Therapeutics's most recent earnings report was on Mar 3, 2025

When does Repare Therapeutics report earnings?

The next expected earnings date for Repare Therapeutics is May 7, 2025

Should I buy Repare Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page